182 related articles for article (PubMed ID: 8897062)
1. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
[TBL] [Abstract][Full Text] [Related]
2. Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.
Tomaru T; Fujimori Y; Nakamura F; Aoki N; Sakamoto Y; Kawai K; Omata M; Uchida Y
Heart Vessels; 1996; 11(3):123-32. PubMed ID: 8897061
[TBL] [Abstract][Full Text] [Related]
3. Local treatment with antithrombotic drugs can prevent thrombus formation: an angioscopic and angiographic study.
Tomaru T; Nakamura F; Fujimori Y; Omata M; Kawai S; Okada R; Murata Y; Uchida Y
J Am Coll Cardiol; 1995 Nov; 26(5):1325-32. PubMed ID: 7594050
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin and thrombolytic effects of a new antithrombin agent: angioscopic and angiographic comparison with heparin or batroxobin.
Tomaru T; Nakamura F; Miwa AY; Fujimori Y; Omata M; Okada R; Uchida Y
J Interv Cardiol; 1994 Oct; 7(5):409-19. PubMed ID: 10155190
[TBL] [Abstract][Full Text] [Related]
5. Local antithrombotic therapy using a novel porous balloon catheter.
Tomaru T; Kobayakawa N; Onitake A; Nakamura F; Morita T; Uchida Y
Jpn Heart J; 2000 Jan; 41(1):87-95. PubMed ID: 10807533
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery.
Tomaru T; Fujimori Y; Morita T; Aoki N; Sakamoto Y; Nakamura F; Omata M; Uchida Y
Jpn Circ J; 1996 Dec; 60(12):981-92. PubMed ID: 8996689
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries.
Tomaru T; Kawano HA; Tsujiuchi Y; Suzuki J; Nakajima T; Uchida Y
Life Sci; 2005 Oct; 77(21):2611-25. PubMed ID: 16005470
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive Therapy with an Antithrombotic Drug Can Prevent Reocclusion and Induce Residual Thrombus Reduction After Percutaneous Transcatheter Angioplasty of the Thrombotic Lesions.
Kawano H; Tomaru T; Omata M; Okada R; Uchida Y
J Thromb Thrombolysis; 1997; 4(2):293-300. PubMed ID: 10639273
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
[TBL] [Abstract][Full Text] [Related]
11. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
Imura Y; Stassen JM; Collen D
J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
[TBL] [Abstract][Full Text] [Related]
12. Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.
Berry CN; Visconte C; Lecoffre C; Lochot S; Girard D
Thromb Haemost; 2000 Aug; 84(2):286-90. PubMed ID: 10959702
[TBL] [Abstract][Full Text] [Related]
13. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.
Sabatine MS; Tu TM; Jang IK
J Thromb Thrombolysis; 2000 Oct; 10(2):189-96. PubMed ID: 11005941
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
Tomaru T; Uchida Y; Nakamura F; Sonoki H; Tsukamoto M; Sugimoto T
Am Heart J; 1989 Feb; 117(2):275-81. PubMed ID: 2492737
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
Berry CN; Girard D; Lochot S; Lecoffre C
Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
[TBL] [Abstract][Full Text] [Related]
16. Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model.
Kruse KR; Crowley JJ; Tanguay JF; Santos RM; Millare DS; Phillips HR; Zidar JP; Stack RS
Catheter Cardiovasc Interv; 1999 Apr; 46(4):503-7. PubMed ID: 10216025
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
[TBL] [Abstract][Full Text] [Related]
18. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
19. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
Roux S; Tschopp T; Baumgartner HR
J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation.
Sasaki Y; Morii S; Yamashita T; Yamamoto J
Haemostasis; 1993; 23(2):104-11. PubMed ID: 8365687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
